Sangamo Therapeutics Inc (LTS:0R1D)
$ 2.18 -0.06 (-2.68%) Market Cap: 492.41 Mil Enterprise Value: 480.93 Mil PE Ratio: 0 PB Ratio: 12.55 GF Score: 41/100

Sangamo Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

May 24, 2022 / 11:00AM GMT
Release Date Price: $3.62 (-11.61%)
Jason Shieh
H.C. Wainwright & Co, LLC, Research Division - Associate of Equity Research

Hello, everyone, and thank you for joining the H.C. Wainwright 2022 Global Investment Hybrid Conference. My name is Jason Shieh, and I'm an Associate Analyst with H.C. Wainwright.

While we are hybrid this year, we're confident we are going to be able to provide value to you with more than 550 companies presenting at this conference in multiple sector tracks devoted to life science, cryptocurrency, blockchain and fintech, technology, media and telecommunications, cleantech and growth.

H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. We have a total of 24 publishing senior analysts and more than 648 companies covered across all sectors. Please visit hcwco.com for more information.

The in-person venue for the event is in the Fontainebleau Hotel in Miami. Virtual participations will be staged simultaneously with over 550 companies'

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot